About Zosano pharma
Zosano Pharma is a rapidly growing CNS (Central Nervous System) company that specializes in providing quick relief to patients using well-established and safe therapeutics. The company has been at the forefront of developing innovative solutions for various CNS disorders, including migraines, cluster headaches, and osteoporosis.
The company's mission is to improve the lives of patients suffering from debilitating conditions by providing them with fast-acting treatments that are both effective and safe. Zosano Pharma has a team of highly skilled professionals who are dedicated to discovering new ways to treat CNS disorders.
One of the key strengths of Zosano Pharma is its focus on innovation. The company invests heavily in research and development, constantly exploring new avenues for treating CNS disorders. This approach has led to several breakthroughs in recent years, including the development of a novel transdermal microneedle patch technology that delivers therapeutic agents through the skin.
Zosano Pharma's flagship product is Qtrypta™ (zolmitriptan transdermal microneedle system), which was recently approved by the FDA for acute treatment of migraine with or without aura in adults. Qtrypta™ offers rapid relief from migraines without causing any adverse side effects commonly associated with oral medications.
Apart from Qtrypta™, Zosano Pharma also has several other products under development that target different CNS disorders such as Parkinson's disease and Alzheimer's disease. These products are currently undergoing clinical trials and have shown promising results so far.
Zosano Pharma operates on a global scale, with offices located across North America and Europe. The company has established partnerships with leading pharmaceutical companies worldwide to expand its reach further.
In conclusion, Zosano Pharma is an emerging leader in the field of CNS therapeutics known for its innovative approach towards treating debilitating conditions such as migraines and cluster headaches quickly. With its focus on research & development coupled with strategic partnerships worldwide, it aims to provide effective solutions for various CNS disorders while ensuring patient safety remains paramount at all times.